BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33730730)

  • 1. Targeted Therapy in Patients with Metastatic Male Germ Cell Tumors.
    Heidenreich A; Paffenholz P; Nestler T; Tolkach Y; Pfister D
    Urol Int; 2021; 105(7-8):720-723. PubMed ID: 33730730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
    Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
    J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged regression of metastatic tumors of the testis: rejections on prognosis].
    Gayet R; Cabanne F; Guerrin J
    J Urol Nephrol (Paris); 1976; 82(10-11):913-6. PubMed ID: 187807
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathologic Characterization of Bilateral Testicular Germ Cell Tumors With Immunohistochemical Evaluation of Mismatch Repair and
    Al-Obaidy KI; Trevino KE; Idrees MT
    Int J Surg Pathol; 2019 Sep; 27(6):619-623. PubMed ID: 30983459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optic metastasis in a metastatic embryonic cell testicular cancer].
    Ritzel RM; Ruf C; Schlegel HM
    Rofo; 2007 Nov; 179(11):1196-7. PubMed ID: 17948200
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of postchemotherapy surgery in managing metastatic germ cell tumors.
    Beck SD
    Cancer; 2007 Dec; 110(12):2601-3, i. PubMed ID: 17948907
    [No Abstract]   [Full Text] [Related]  

  • 7. Anatomo-surgical aspects after chemotherapy for metastatic germ-cell tumors.
    Le Duc A; Le Doze H; Mignot L; Gisselbrecht C; Hoang C
    Prog Clin Biol Res; 1985; 203():69-80. PubMed ID: 3008191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of testicular germ cell tumors: pathogenesis and mechanisms of therapy resistance.
    Al-Obaidy KI; Chovanec M; Cheng L
    Expert Rev Anticancer Ther; 2020 Feb; 20(2):75-79. PubMed ID: 31951790
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathologic findings at orchiectomy following chemotherapy for disseminated testicular cancer.
    Greist A; Einhorn LH; Williams SD; Donohue JP; Rowland RG
    J Clin Oncol; 1984 Sep; 2(9):1025-7. PubMed ID: 6088708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?
    Simmonds PD; Mead GM; Lee AH; Theaker JM; Dewbury K; Smart CJ
    Cancer; 1995 Feb; 75(4):1018-24. PubMed ID: 7842403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Three case reports of metastatic germ cell tumors in the lumbar vertebra during first-line chemotherapy].
    Dobashi M; Son S; Ikeda M; Fujita T; Matsumoto K; Satoh T; Iwamura M; Baba S
    Hinyokika Kiyo; 2008 Dec; 54(12):803-7. PubMed ID: 19175007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapeutic treatment regimens for germinal testicular tumors].
    Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
    Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
    [No Abstract]   [Full Text] [Related]  

  • 14. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
    Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
    Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker.
    Gokce MI; Mermerkaya M; Süer E; Afandiyev F; Baltaci S
    Minerva Urol Nefrol; 2017 Aug; 69(4):342-348. PubMed ID: 27733750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
    McKendrick JJ; Mead GM; Cowlishaw D
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):128-31. PubMed ID: 12801050
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted treatment approaches in refractory germ cell tumors.
    Galvez-Carvajal L; Sanchez-Muñoz A; Ribelles N; Saez M; Baena J; Ruiz S; Ithurbisquy C; Alba E
    Crit Rev Oncol Hematol; 2019 Nov; 143():130-138. PubMed ID: 31634730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational targeted therapies for the treatment of testicular germ cell tumors.
    Oing C; Kollmannsberger C; Oechsle K; Bokemeyer C
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1033-43. PubMed ID: 27286362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate for relapse of metastatic non-seminomatous germ-cell tumours.
    Atkinson CH; Horwich A; Peckham MJ
    Med Oncol Tumor Pharmacother; 1987; 4(1):33-7. PubMed ID: 3037206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.